feed,title,long_url,short_url
Benzinga,Tiziana Receives Sign-Off From The FDA To Proceed With Phase 2 Clinical Trial In Patients With Non-Active Secondary Progressive Multiple Sclerosis (SPMS),https://benzinga.com/general/biotech/23/03/31545325/tiziana-receives-sign-off-from-the-fda-to-proceed-with-phase-2-clinical-trial-in-patients-with-no,https://da.gd/iQ86O
